vs

Side-by-side financial comparison of Groupon, Inc. (GRPN) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

Groupon, Inc. is the larger business by last-quarter revenue ($132.7M vs $69.8M, roughly 1.9× RIGEL PHARMACEUTICALS INC). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 6.0%, a 378.1% gap on every dollar of revenue. On growth, RIGEL PHARMACEUTICALS INC posted the faster year-over-year revenue change (21.2% vs 1.8%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs 3.8%).

Groupon, Inc. is an American e-commerce marketplace that connects subscribers with local merchants by offering activities, travel, goods, and services in 13 countries.

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

GRPN vs RIGL — Head-to-Head

Bigger by revenue
GRPN
GRPN
1.9× larger
GRPN
$132.7M
$69.8M
RIGL
Growing faster (revenue YoY)
RIGL
RIGL
+19.4% gap
RIGL
21.2%
1.8%
GRPN
Higher net margin
RIGL
RIGL
378.1% more per $
RIGL
384.0%
6.0%
GRPN
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
3.8%
GRPN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GRPN
GRPN
RIGL
RIGL
Revenue
$132.7M
$69.8M
Net Profit
$7.9M
$268.1M
Gross Margin
90.4%
91.5%
Operating Margin
4.9%
33.2%
Net Margin
6.0%
384.0%
Revenue YoY
1.8%
21.2%
Net Profit YoY
115.8%
1769.2%
EPS (diluted)
$0.21
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GRPN
GRPN
RIGL
RIGL
Q4 25
$132.7M
$69.8M
Q3 25
$122.8M
$69.5M
Q2 25
$125.7M
$101.7M
Q1 25
$117.2M
$53.3M
Q4 24
$130.4M
$57.6M
Q3 24
$114.5M
$55.3M
Q2 24
$124.6M
$36.8M
Q1 24
$123.1M
$29.5M
Net Profit
GRPN
GRPN
RIGL
RIGL
Q4 25
$7.9M
$268.1M
Q3 25
$-118.4M
$27.9M
Q2 25
$20.3M
$59.6M
Q1 25
$7.2M
$11.4M
Q4 24
$-50.1M
$14.3M
Q3 24
$13.9M
$12.4M
Q2 24
$-10.0M
$-1.0M
Q1 24
$-12.3M
$-8.2M
Gross Margin
GRPN
GRPN
RIGL
RIGL
Q4 25
90.4%
91.5%
Q3 25
91.1%
93.2%
Q2 25
91.0%
95.6%
Q1 25
90.7%
91.7%
Q4 24
90.6%
89.9%
Q3 24
89.9%
85.5%
Q2 24
90.4%
92.4%
Q1 24
89.8%
93.1%
Operating Margin
GRPN
GRPN
RIGL
RIGL
Q4 25
4.9%
33.2%
Q3 25
1.8%
40.9%
Q2 25
10.4%
60.1%
Q1 25
1.6%
23.9%
Q4 24
2.0%
28.9%
Q3 24
-4.9%
25.4%
Q2 24
3.5%
1.2%
Q1 24
6.0%
-23.6%
Net Margin
GRPN
GRPN
RIGL
RIGL
Q4 25
6.0%
384.0%
Q3 25
-96.4%
40.2%
Q2 25
16.2%
58.6%
Q1 25
6.1%
21.5%
Q4 24
-38.4%
24.9%
Q3 24
12.2%
22.5%
Q2 24
-8.1%
-2.8%
Q1 24
-10.0%
-27.9%
EPS (diluted)
GRPN
GRPN
RIGL
RIGL
Q4 25
$0.21
$14.11
Q3 25
$-2.92
$1.46
Q2 25
$0.46
$3.28
Q1 25
$0.17
$0.63
Q4 24
$-1.26
$0.82
Q3 24
$0.33
$0.70
Q2 24
$-0.25
$-0.06
Q1 24
$-0.33
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GRPN
GRPN
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$296.1M
$155.0M
Total DebtLower is stronger
$342.8M
$52.5M
Stockholders' EquityBook value
$-42.6M
$391.5M
Total Assets
$670.4M
$513.6M
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GRPN
GRPN
RIGL
RIGL
Q4 25
$296.1M
$155.0M
Q3 25
$238.5M
$137.1M
Q2 25
$262.6M
$108.4M
Q1 25
$226.8M
$77.1M
Q4 24
$228.8M
$77.3M
Q3 24
$159.7M
$61.1M
Q2 24
$178.1M
$49.1M
Q1 24
$158.7M
$49.5M
Total Debt
GRPN
GRPN
RIGL
RIGL
Q4 25
$342.8M
$52.5M
Q3 25
$60.0M
Q2 25
$60.0M
Q1 25
$60.0M
Q4 24
$246.0M
$60.0M
Q3 24
$60.0M
Q2 24
$60.0M
Q1 24
$60.0M
Stockholders' Equity
GRPN
GRPN
RIGL
RIGL
Q4 25
$-42.6M
$391.5M
Q3 25
$-59.6M
$117.6M
Q2 25
$51.2M
$81.9M
Q1 25
$45.5M
$18.6M
Q4 24
$40.8M
$3.3M
Q3 24
$40.0M
$-14.6M
Q2 24
$40.2M
$-29.9M
Q1 24
$41.2M
$-31.7M
Total Assets
GRPN
GRPN
RIGL
RIGL
Q4 25
$670.4M
$513.6M
Q3 25
$608.2M
$242.5M
Q2 25
$647.4M
$206.7M
Q1 25
$608.2M
$176.0M
Q4 24
$612.7M
$164.0M
Q3 24
$548.0M
$139.4M
Q2 24
$572.8M
$128.4M
Q1 24
$580.5M
$126.5M
Debt / Equity
GRPN
GRPN
RIGL
RIGL
Q4 25
0.13×
Q3 25
0.51×
Q2 25
0.73×
Q1 25
3.23×
Q4 24
6.03×
18.25×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GRPN
GRPN
RIGL
RIGL
Operating Cash FlowLast quarter
$56.6M
$22.0M
Free Cash FlowOCF − Capex
$53.0M
FCF MarginFCF / Revenue
40.0%
Capex IntensityCapex / Revenue
2.7%
Cash ConversionOCF / Net Profit
7.13×
0.08×
TTM Free Cash FlowTrailing 4 quarters
$49.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GRPN
GRPN
RIGL
RIGL
Q4 25
$56.6M
$22.0M
Q3 25
$-20.5M
$24.0M
Q2 25
$28.4M
$30.5M
Q1 25
$-22.0K
$-893.0K
Q4 24
$67.0M
$14.5M
Q3 24
$-16.3M
$21.7M
Q2 24
$15.3M
$302.0K
Q1 24
$-10.1M
$-5.0M
Free Cash Flow
GRPN
GRPN
RIGL
RIGL
Q4 25
$53.0M
Q3 25
$-24.6M
Q2 25
$25.2M
Q1 25
$-3.8M
Q4 24
$63.2M
Q3 24
$-19.7M
Q2 24
$10.8M
Q1 24
$-13.8M
FCF Margin
GRPN
GRPN
RIGL
RIGL
Q4 25
40.0%
Q3 25
-20.0%
Q2 25
20.0%
Q1 25
-3.2%
Q4 24
48.5%
Q3 24
-17.2%
Q2 24
8.7%
Q1 24
-11.2%
Capex Intensity
GRPN
GRPN
RIGL
RIGL
Q4 25
2.7%
Q3 25
3.3%
Q2 25
2.6%
Q1 25
3.2%
Q4 24
2.9%
Q3 24
3.0%
Q2 24
3.6%
Q1 24
3.0%
Cash Conversion
GRPN
GRPN
RIGL
RIGL
Q4 25
7.13×
0.08×
Q3 25
0.86×
Q2 25
1.40×
0.51×
Q1 25
-0.00×
-0.08×
Q4 24
1.01×
Q3 24
-1.17×
1.75×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GRPN
GRPN

Service Local$94.8M71%
Other$35.6M27%
Service Travel$2.3M2%

RIGL
RIGL

Segment breakdown not available.

Related Comparisons